Companies struggle to measure well at the front end of innovation
We think companies can measure better all along the innovation pipeline, but if you asked us what sorts of activities need the most improvement vis-à-vis
Your MVP is useless without innovation accounting – Innovation Book Series
Ask people in the startup or innovation community about Eric Ries’ The Lean Startup, and I bet “innovation accounting” won’t come up in 9 out
Why ‘Dead Reckoning’?
We thought we’d better go ahead and address this one right up front. What is “dead reckoning” and why on earth would we pick that
More efficient innovation may be critical to staying competitive
One of the reasons we started Commodore was concern about a decline in Total Factor Productivity (TFP) in many major economies (e.g., US, China, the
Innovation metrics: choose carefully to avoid being disrupted
With this blog post we launch an occasional series exploring what some of the best innovation books say about measuring and evaluating innovation. Since you’re
Why is everyone dissatisfied with innovation?
Over the last ten years—both in my practice as an innovation consultant and in the literature—I’ve seen a recurring theme among people responsible for growth
The way we measure innovation hasn’t changed in 10 years.
The way companies measure innovation initiatives is outdated. Despite all the progress that has been made in innovation practice in the last decade, firms are still
What Osterwalder gets wrong (and right) about innovation metrics
What does the firm behind the business model canvas have to say about innovation metrics?
Nordic Study: 3 Common Problems With Innovation Metrics
A recently published study, by Ilse Svensson de Jong, highlights three problems with innovation metrics that can seriously hurt firms’ innovation efforts.
What a recent HBR article gets wrong (and right) about innovation metrics
A recent HBR article (here) claims that use of innovation metrics (especially financial metrics) too early will “suffocate” your most promising innovations. The author, Scott
R&D investment grew by nearly 12% in Q4 of 2020
Pharmaceutical firms drove R&D investment higher by nearly 12% in Q4 of 2020.
After a strong Q3, where next for innovation investment?
Innovation spending grew strongly in Q3. But how will your competitors respond to increasing pressure on budgets as the economic outlook worsens? Review their spending patterns in our data visualization tool.
Will AI dramatically alter the economics of innovation?
What will AI mean for innovation productivity? We review the fundamentals (which look strong) and some examples of AI in innovation (which are exciting, but lack high-quality data on impact).
Budget cuts are here. Time to bolster the case for innovation.
Innovation teams are facing budget constraints for the remainder of 2020 and into 2021. But the impact of COVID-19 means innovation is more important than ever. Act now to bolster the case for sustained investment in innovation.
COVID-19: Your innovation strategy’s been updated. Now what?
Many firms are updating their innovation strategies in response to COVID-19. Those changes will only be implemented if they are effectively communicated.
COVID-19: Business R&D Spending Will Fall by at Least 5-6%
With a recession imminent, innovation leaders will soon be facing budget pressure. We look back at R&D spending in recent US recessions to understand what might be coming—and consider how to prepare.
How to improve measurement of innovation performance in your organization.
Our advice to organizations who are deciding to do something to improve their innovation performance measurement system, including when to do it in-house and when to get outside help.